WealthTech Founder's Lab Information

You're not stuck. You're undiagnosed. Get your labs done. Most WealthTech founders don't have a product problem. They have a readiness and adoption problem — and nobody in the room has an incentive to tell them that directly. Investors keep optionality open. Buyers avoid conflict. So founders spend six, twelve, eighteen months mistaking polite interest for momentum. The hard part was never the idea. It was never even the product. The hard part is everything the market tests you on that you didn't know you'd be tested on. WealthTech Founders Lab closes the two gaps that actually explain why good WealthTech stalls. The Readiness Gap: the founder isn't ready for the next room they're trying to enter. The story doesn't hold. The proof doesn't survive scrutiny. The meetings happen — and nothing converts. The Adoption Gap: the product may work, but it isn't choosable. Buyers don't change behavior. Pilots stall. The founder is speaking builder language while the market is making workflow and risk decisions. We work from both sides of the table. Dr. Joshua Wilson brings the buyer side — active work with RIAs and advisory firms, and the behavioral science of why buyers actually say yes or no. Marshall Smith brings the capital side — First Rate Ventures, 100+ WealthTech pitches reviewed per year. Start with the WTFL Growth Labs. A clinical read on your company from both sides — what's strong, what's exposed, and what to fix before you spend another dollar finding out the hard way. Not a pep talk. A diagnosis. www.youtube.com/@WealthTechFoundersLab